drugset / Trial / NCT03902002
A Pharmacokinetic Study of Omaveloxolone in Subjects With Hepatic Impairment and Normal Hepatic Function
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study will examine the pharmacokinetics (PK) of omaveloxolone following a single oral dose of omaveloxolone in subjects with mild, moderate, or severe hepatic impairment compared to healthy subjects with normal hepatic function.
Timeline
- Start
- 2019-07-19
- Primary completion
- 2020-01-27
- Completion
- 2020-01-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Omaveloxolone | Small molecule | 150 mg | Oral |
Indications
No indication recorded.